1. Home
  2. ICUI vs HSAI Comparison

ICUI vs HSAI Comparison

Compare ICUI & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$131.20

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Hesai Group each ADS represents one Class B ordinary share

HSAI

Hesai Group each ADS represents one Class B ordinary share

HOLD

Current Price

$21.89

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICUI
HSAI
Founded
1984
2014
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.8B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
ICUI
HSAI
Price
$131.20
$21.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$178.50
$31.58
AVG Volume (30 Days)
229.9K
2.1M
Earning Date
05-07-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
100.62
N/A
EPS
0.03
N/A
Revenue
$2,231,262,000.00
N/A
Revenue This Year
N/A
$46.32
Revenue Next Year
$4.46
$41.24
P/E Ratio
$4,330.17
$61.18
Revenue Growth
N/A
N/A
52 Week Low
$107.02
$12.06
52 Week High
$160.29
$30.85

Technical Indicators

Market Signals
Indicator
ICUI
HSAI
Relative Strength Index (RSI) 53.24 46.66
Support Level $130.63 $20.00
Resistance Level $133.62 $23.98
Average True Range (ATR) 4.31 1.02
MACD 1.31 0.40
Stochastic Oscillator 99.24 56.02

Price Performance

Historical Comparison
ICUI
HSAI

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

Share on Social Networks: